Household Healthcare Sector

Milestone Scientific

Market Cap: US$82.3m

A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

Imugene

Market Cap: AU$126.9m

A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

Galectin Therapeutics

Market Cap: US$81.6m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

Armata Pharmaceuticals

Market Cap: US$81.4m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Genenta Science

Market Cap: US$81.4m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Auxly Cannabis Group

Market Cap: CA$112.0m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Sera Prognostics

Market Cap: US$79.9m

A women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.

Sensus Healthcare

Market Cap: US$79.2m

Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Arch Biopartners

Market Cap: US$79.1m

Engages in the development of novel drugs for acute kidney injury and organ damage in Canada.

Satellos Bioscience

Market Cap: CA$109.5m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Alto Neuroscience

Market Cap: US$78.8m

Operates as a clinical-stage biopharmaceutical company in the United States.

Protect Pharmaceutical

Market Cap: US$78.7m

Primarily focuses on crop farming and agricultural businesses.

NetraMark Holdings

Market Cap: CA$109.0m

Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.

Inovio Pharmaceuticals

Market Cap: US$78.1m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Tenaya Therapeutics

Market Cap: US$77.4m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Planet 13 Holdings

Market Cap: CA$107.3m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

4DMedical

Market Cap: AU$119.4m

Operates as a medical technology company in the United States and Australia.

CervoMed

Market Cap: US$76.4m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Adaptimmune Therapeutics

Market Cap: US$76.1m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Sutro Biopharma

Market Cap: US$76.0m

Operates as a oncology company.

e-therapeutics

Market Cap: US$76.0m

Engages in drug discovery research activities in the United Kingdom.

Vistagen Therapeutics

Market Cap: US$75.9m

A biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.

Kooth

Market Cap: UK£56.5m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

Jasper Therapeutics

Market Cap: US$75.7m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

Inotiv

Market Cap: US$75.6m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Cumberland Pharmaceuticals

Market Cap: US$75.3m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

Pyxis Oncology

Market Cap: US$75.0m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Veru

Market Cap: US$74.7m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Zynex

Market Cap: US$74.7m

Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

I-Mab

Market Cap: US$74.6m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

IGM Biosciences

Market Cap: US$74.5m

A biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

Elutia

Market Cap: US$74.4m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

BioSig Technologies

Market Cap: US$74.2m

A medical technology company, provides digital signal processing technology platform services in the United States.

PDS Biotechnology

Market Cap: US$74.0m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Global Cord Blood

Market Cap: US$73.7m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Simply Better Brands

Market Cap: CA$101.9m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.